Youssef Aachoui
Concepts (111)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Inflammasomes | 11 | 2024 | 62 | 4.280 |
Why?
| Caspases | 8 | 2022 | 104 | 2.310 |
Why?
| Immunity, Innate | 6 | 2024 | 106 | 1.940 |
Why?
| Neutrophils | 4 | 2024 | 149 | 1.740 |
Why?
| Macrophages | 3 | 2024 | 364 | 1.270 |
Why?
| Phytol | 3 | 2011 | 3 | 1.170 |
Why?
| Adjuvants, Immunologic | 3 | 2011 | 51 | 1.140 |
Why?
| Caspase 1 | 5 | 2022 | 22 | 1.120 |
Why?
| Caspases, Initiator | 5 | 2020 | 9 | 1.110 |
Why?
| Cytosol | 3 | 2020 | 81 | 1.110 |
Why?
| Burkholderia | 4 | 2020 | 11 | 0.990 |
Why?
| Gram-Negative Bacteria | 2 | 2024 | 35 | 0.940 |
Why?
| Cell Death | 3 | 2015 | 175 | 0.850 |
Why?
| Toxins, Biological | 1 | 2022 | 7 | 0.850 |
Why?
| Lipopolysaccharides | 2 | 2020 | 195 | 0.760 |
Why?
| Vaccines | 2 | 2011 | 49 | 0.730 |
Why?
| Interleukin-18 | 3 | 2020 | 27 | 0.720 |
Why?
| Pneumonia, Bacterial | 1 | 2020 | 27 | 0.710 |
Why?
| Interferon-gamma | 3 | 2020 | 176 | 0.680 |
Why?
| Gram-Negative Bacterial Infections | 3 | 2024 | 42 | 0.680 |
Why?
| Cytokines | 6 | 2013 | 612 | 0.650 |
Why?
| Mice | 13 | 2022 | 5671 | 0.600 |
Why?
| Animals | 16 | 2024 | 13133 | 0.590 |
Why?
| Lung | 1 | 2020 | 499 | 0.540 |
Why?
| Neuronal Apoptosis-Inhibitory Protein | 1 | 2016 | 1 | 0.540 |
Why?
| Alum Compounds | 2 | 2011 | 3 | 0.500 |
Why?
| Chemokines | 2 | 2011 | 78 | 0.470 |
Why?
| Intestinal Mucosa | 2 | 2012 | 215 | 0.450 |
Why?
| Vacuoles | 1 | 2013 | 23 | 0.430 |
Why?
| Communicable Diseases | 1 | 2013 | 52 | 0.410 |
Why?
| Adjuvants, Pharmaceutic | 1 | 2011 | 3 | 0.400 |
Why?
| Phosphate-Binding Proteins | 2 | 2022 | 6 | 0.390 |
Why?
| Host-Pathogen Interactions | 2 | 2024 | 136 | 0.380 |
Why?
| Extracellular Matrix | 1 | 2011 | 108 | 0.370 |
Why?
| Autoantibodies | 1 | 2011 | 116 | 0.370 |
Why?
| Calcium-Binding Proteins | 4 | 2020 | 54 | 0.370 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2022 | 139 | 0.370 |
Why?
| Mice, Inbred C57BL | 6 | 2020 | 1795 | 0.370 |
Why?
| Autoimmune Diseases | 1 | 2011 | 101 | 0.360 |
Why?
| Burkholderia Infections | 2 | 2020 | 4 | 0.300 |
Why?
| Mice, Inbred BALB C | 3 | 2011 | 296 | 0.270 |
Why?
| Signal Transduction | 3 | 2020 | 1605 | 0.260 |
Why?
| Apoptosis Regulatory Proteins | 3 | 2020 | 85 | 0.230 |
Why?
| Epithelial Cells | 1 | 2024 | 209 | 0.210 |
Why?
| Cellular Microenvironment | 2 | 2012 | 27 | 0.200 |
Why?
| Immunoglobulin Class Switching | 2 | 2011 | 8 | 0.200 |
Why?
| Phthalic Acids | 2 | 2011 | 4 | 0.200 |
Why?
| Immunity, Humoral | 2 | 2011 | 22 | 0.190 |
Why?
| Intestine, Small | 2 | 2012 | 110 | 0.190 |
Why?
| Brefeldin A | 1 | 2020 | 18 | 0.190 |
Why?
| Bacteria | 1 | 2022 | 218 | 0.180 |
Why?
| Swine | 2 | 2011 | 398 | 0.180 |
Why?
| Interleukin-1beta | 1 | 2020 | 73 | 0.170 |
Why?
| Flow Cytometry | 1 | 2020 | 473 | 0.150 |
Why?
| Humans | 6 | 2024 | 49863 | 0.130 |
Why?
| Th2 Cells | 2 | 2012 | 22 | 0.120 |
Why?
| Killer Cells, Natural | 1 | 2015 | 107 | 0.120 |
Why?
| Bacterial Infections | 1 | 2015 | 93 | 0.120 |
Why?
| Th1 Cells | 2 | 2012 | 53 | 0.120 |
Why?
| Mice, Transgenic | 1 | 2015 | 541 | 0.110 |
Why?
| Lipid A | 1 | 2013 | 4 | 0.110 |
Why?
| Toll-Like Receptor 4 | 1 | 2013 | 51 | 0.110 |
Why?
| Burkholderia pseudomallei | 1 | 2013 | 3 | 0.110 |
Why?
| Salmonella Infections, Animal | 1 | 2013 | 17 | 0.110 |
Why?
| Phagosomes | 1 | 2013 | 19 | 0.110 |
Why?
| Salmonella typhimurium | 1 | 2013 | 48 | 0.110 |
Why?
| Shock, Septic | 1 | 2013 | 78 | 0.100 |
Why?
| Mice, Inbred NZB | 1 | 2011 | 2 | 0.100 |
Why?
| Cross Reactions | 1 | 2011 | 41 | 0.100 |
Why?
| Ovalbumin | 1 | 2011 | 18 | 0.100 |
Why?
| Haptens | 1 | 2011 | 10 | 0.100 |
Why?
| Ascitic Fluid | 1 | 2011 | 12 | 0.100 |
Why?
| Protein Array Analysis | 1 | 2011 | 23 | 0.100 |
Why?
| Emulsions | 1 | 2011 | 25 | 0.100 |
Why?
| Diterpenes | 1 | 2011 | 30 | 0.100 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 42 | 0.090 |
Why?
| Female | 4 | 2020 | 26520 | 0.090 |
Why?
| Transcriptional Activation | 1 | 2011 | 118 | 0.090 |
Why?
| Necrosis | 1 | 2011 | 175 | 0.090 |
Why?
| Models, Animal | 1 | 2011 | 229 | 0.090 |
Why?
| Immunoglobulin G | 1 | 2011 | 188 | 0.090 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 594 | 0.090 |
Why?
| Carrier Proteins | 1 | 2011 | 302 | 0.080 |
Why?
| Vaccination | 1 | 2011 | 275 | 0.080 |
Why?
| Staphylococcus aureus | 1 | 2012 | 327 | 0.080 |
Why?
| Genetic Predisposition to Disease | 1 | 2011 | 507 | 0.080 |
Why?
| DNA | 1 | 2011 | 539 | 0.080 |
Why?
| Inflammation | 1 | 2011 | 602 | 0.070 |
Why?
| Gene Expression Profiling | 1 | 2011 | 1029 | 0.070 |
Why?
| Apoptosis | 1 | 2011 | 1102 | 0.060 |
Why?
| Male | 1 | 2020 | 25439 | 0.040 |
Why?
| Chromobacterium | 1 | 2015 | 1 | 0.030 |
Why?
| Granulomatous Disease, Chronic | 1 | 2015 | 4 | 0.030 |
Why?
| Listeriosis | 1 | 2015 | 7 | 0.030 |
Why?
| Listeria monocytogenes | 1 | 2015 | 11 | 0.030 |
Why?
| Spleen | 1 | 2015 | 170 | 0.030 |
Why?
| Francisella | 1 | 2013 | 1 | 0.030 |
Why?
| Cross-Priming | 1 | 2013 | 1 | 0.030 |
Why?
| Poly I-C | 1 | 2013 | 4 | 0.030 |
Why?
| Salmonella | 1 | 2013 | 26 | 0.030 |
Why?
| Salmonella Infections | 1 | 2013 | 17 | 0.030 |
Why?
| CD30 Ligand | 1 | 2012 | 1 | 0.030 |
Why?
| Chemokines, CC | 1 | 2012 | 7 | 0.030 |
Why?
| Chemokine CX3CL1 | 1 | 2012 | 9 | 0.030 |
Why?
| Enzyme Activation | 1 | 2013 | 273 | 0.030 |
Why?
| Guided Tissue Regeneration | 1 | 2012 | 4 | 0.030 |
Why?
| Inflammation Mediators | 1 | 2012 | 110 | 0.030 |
Why?
| Wound Healing | 1 | 2012 | 204 | 0.020 |
Why?
| Liver | 1 | 2015 | 1110 | 0.020 |
Why?
| Models, Biological | 1 | 2012 | 722 | 0.020 |
Why?
| Gene Expression Regulation | 1 | 2012 | 972 | 0.020 |
Why?
|
|
Aachoui's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|